Fortress Biotech, Inc. (NASDAQ:FBIOP – Get Free Report) saw a significant increase in short interest in the month of April. As of April 15th, there was short interest totalling 9,500 shares, an increase of 97.9% from the March 31st total of 4,800 shares. Based on an average trading volume of 12,800 shares, the days-to-cover ratio is currently 0.7 days.
Fortress Biotech Stock Up 3.9 %
Shares of NASDAQ FBIOP traded up $0.52 during midday trading on Friday, reaching $13.82. 4,596 shares of the company traded hands, compared to its average volume of 13,002. The stock’s 50-day simple moving average is $15.90 and its 200-day simple moving average is $13.56. Fortress Biotech has a 12 month low of $6.40 and a 12 month high of $18.91.
Fortress Biotech Announces Dividend
The company also recently disclosed a monthly dividend, which will be paid on Tuesday, April 30th. Shareholders of record on Monday, April 15th will be issued a dividend of $0.1953 per share. The ex-dividend date of this dividend is Friday, April 12th. This represents a $2.34 annualized dividend and a yield of 16.96%.
Fortress Biotech Company Profile
Fortress Biotech, Inc, a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino an oral minocycline drug for the treatment of moderate to severe acne; Targadox an oral doxycycline drug for adjunctive therapy for severe acne; Exelderm cream for antifungal intended for topical use; Qbrexza a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Amzeeq; Zilxi; and Accutane capsules for severe recalcitrant nodular acne.
See Also
- Five stocks we like better than Fortress Biotech
- High Dividend REITs: Are They an Ideal Way to Diversify?
- MarketBeat Week in Review – 4/22 – 4/26
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- 3 Stocks Leading the U.S. Agriculture Comeback
- Manufacturing Stocks Investing
- How to Use Put Debit Spreads to Profit From Falling Stocks
Receive News & Ratings for Fortress Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fortress Biotech and related companies with MarketBeat.com's FREE daily email newsletter.